Sign in

CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company

NRX Pharmaceuticals, Inc.

Sign in to watch
Ticker
NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822844431
Phone
484-254-6134
Business address
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
Former names
Big Rock Partners Acquisition Corp.
  1. 10-K Report Annual Report
  2. 8-K Event Results of operations
  3. 424B5 Offering Prospectus
  4. 8-K/A Event Material agreement · Regulation FD disclosure
  5. 8-K Event Regulation FD disclosure
  6. 424B5 Offering Prospectus
  7. 8-K Event Material agreement · Regulation FD disclosure
  8. 8-K Event Shareholder vote results
  9. 8-K Event Shareholder vote results · Other events
  10. 8-K Event Executive or director change
  11. 5 Insider Annual Insider Trading Report
  12. 8-K Event Other events
  13. 8-K Event Shareholder vote results · Other events
  14. DEF 14A Proxy Proxy Statement
  15. PRE 14A Proxy Proxy Statement (Preliminary)
  16. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 50,000 shares at $1.17 ($58,500)
  17. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 30,000 shares at $1.10 ($33,000)
  18. 4/A Open-market buy CHIEF FINANCIAL OFFICER bought 16,337 shares at an average $1.11 ($18,215)
  19. 4 Open-market sale Director sold 400,000 shares at $1.00 ($400,000)
  20. 424B5 Offering Prospectus

Page 9 of 24 · 479 filings